C. . Li, Z. . Yang, J. . Xie, and Y. Long, “A Novel Multi-analyte Serum Panel Combining CA-125, HE4, microRNA-200a, and Interleukin-6 for the Preclinical Detection of High-Grade Serous Ovarian Carcinoma in Women with Pathogenic *BRCA1/2* Variants: Serum CA-125, HE4, microRNA-200a, and Interleukin- Serous Ovarian Carcinoma”, J Med Biochem, Jun. 2026, doi: 10.5937/jomb0-65630.